Accessibility Tools
[contact-form-7 404 "Not Found"]
x

An anterior cruciate ligament (ACL) implant that offers an alternative to traditional ACL reconstruction has received marketing authorization from the U.S. Food and Drug Administration-the first approval for an ACL tear treatment in more than 30 years.

The Bridge-Enhanced ACL Repair (BEAR) Implant received approval under the De Novo premarket review pathway, the FDA regulatory pathway for low- to moderate-risk devices of a new type.

Source: Medical Xpress

Read More